Detalles de la búsqueda
1.
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy.
Br J Cancer
; 129(10): 1619-1624, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749283
2.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer
; 30(3): 2455-2465, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779921
3.
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
Curr Treat Options Oncol
; 22(8): 69, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110510
4.
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO).
Support Care Cancer
; 29(2): 851-858, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32504310
5.
The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
Br J Cancer
; 117(3): 315-321, 2017 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28632725
6.
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial.
Br J Cancer
; 117(8): 1099-1104, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28926529
7.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 22(12): 1463-1469, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860412
8.
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.
Gastric Cancer
; 20(1): 156-163, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26796888
9.
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Gastric Cancer
; 20(5): 825-833, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028664
10.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28976226
11.
Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab.
J Transl Med
; 13: 140, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25943333
12.
[Treatment of pancreatic cancer. Actuality and perspective]. / Trattamento del carcinoma del pancreas. Attualità e prospettive.
Recenti Prog Med
; 106(5): 208-16, 2015 May.
Artículo
en Italiano
| MEDLINE | ID: mdl-25994537
13.
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
Int J Cancer
; 135(5): 1247-56, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24510746
14.
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management.
BMC Cancer
; 14: 110, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24552144
15.
Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice.
Future Oncol
; 10(14): 2103-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25471023
16.
Translational challenges from the 2014 Gastrointestinal Cancers Symposium: toward a true tailored therapy through effective research.
Future Oncol
; 10(7): 1125-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947252
17.
The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
Molecules
; 19(5): 6393-406, 2014 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24853455
18.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Eur J Cancer
; 200: 113587, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340384
19.
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Oncologist
; 23(2): 272, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449512
20.
Role of ß4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab.
Future Oncol
; 9(8): 1207-14, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23617461